The ORL-1 Receptor System: Are There Opportunities for Antagonists in Pain Therapy?

E-ISSN： 1873-4294|8|16|1442-1451

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.16, 2008-11, pp. : 1442-1451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances towards the discovery of ORL-1 receptor agonists and antagonists

By Bignan Gilles C Connolly Peter J Middleton Steven A

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 357-388

Informa Healthcare

Access to resources Recommend Favorite

Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists

By Ronzoni S. Peretto I. Giardina G.A.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 525-546

Informa Healthcare

Access to resources Recommend Favorite

NK 1 receptor antagonists - are they really without effect in the pain clinic?

By Laszlo A. Fox A.J.

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 462-464

Elsevier

Access to resources Recommend Favorite

NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1820-1831

Bentham Science Publishers

Access to resources Recommend Favorite

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor

By Meunier J.-C.

European Journal of Pharmacology, Vol. 340, Iss. 1, 1997-12 ,pp. : 1-15

Elsevier

Access to resources Recommend Favorite